Dermacyd Infantile (Lactic Acid) - Photo Evaluation.
Phase 4
Completed
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- Registration Number
- NCT00881348
- Lead Sponsor
- Sanofi
- Brief Summary
Primary Objective:
To demonstrate the absence of photo irritation and photosensitization potential of the product Dermacyd Infantile (Lactic Acid).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Dermacyd infantile (Lactic Acid) LACTIC ACID(ND) 5 weeks treatment
- Primary Outcome Measures
Name Time Method The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type. During 5 weeks (i.e. treatment period)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms by which lactic acid prevents photo irritation in infants?
How does lactic acid compare to other alpha hydroxy acids in managing infant skin hygiene?
Are there specific biomarkers that indicate lactic acid efficacy in neonatal dermatological care?
What adverse events are associated with lactic acid use in photoprotective infant skincare products?
What alternative compounds or combination therapies are being explored for infantile photosensitivity prevention by Sanofi or competitors?
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil
Sanofi-Aventis Administrative Office🇧🇷Sao Paulo, Brazil